1: Okyo Pharma and the roadmap to IND submission to the FDA for dry eye treatment in 2022
1 tracks • 0 plays • 0 favorites
1: Okyo Pharma and the roadmap to IND submission to the FDA for dry eye treatment in 2022
Betsnat Bt
0:007:57
Business & Finance
Episodes
1
1: Okyo Pharma and the roadmap to IND submission to the FDA for dry eye treatment in 2022
Betsnat Bt